Green Cross acquires the first tetravalent flu vaccine for multiple injections in Korea

Published: 2016-05-24 11:40:39

Updated: 2016-05-24 11:40:39

On the 23^rd, Green Cross(CEO Eun-cheol Huh) announced product approval of ‘GCFlu Quadrivalent Multi Inj,’ an tetravalent influenza vaccine, from the Ministry of Food and Drug Safety on the 20^th.

The tetravalent influenza vaccine approved on Green Cross is a multi-injectable vial formulation which contains 10 injections for adults; this is the first time for a Korean company to acquire approval...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.